CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $364K of Corcept Therapeutics Incorporated
Sold$364,070
$80.90Price
4,500Shares
−85%Stake
What CORT did after the filing
- The stock from Thu, Dec 4 open, $84.35
- −58.2%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Jan 20 close.
Traded Tue, Nov 25. Filed Wed, Dec 3. Returns use the Dec 4 open and the Jan 20 close. Not investment advice.